Table 4.
Time trend in aAARs of NGB over the period 1993–2017 by sex (Standard: Europe 2013).
| Period | Male | Female | Both sexes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. | CR | AAR | 95%CI | No. | CR | AAR | 95%CI | No. | CR | AAR | 95%CI | ||
| 1993–1995 | 66 | 5.00 | 5.41 | 3.96–6.86 | 60 | 4.05 | 3.72 | 2.71–4.73 | 126 | 4.50 | 4.46 | 3.61–5.30 | |
| 1996–1998 | 61 | 4.74 | 4.76 | 3.43–6.09 | 47 | 3.26 | 2.87 | 2.00-3.75 | 108 | 3.96 | 3.72 | 2.96–4.48 | |
| 1999–2001 | 64 | 5.10 | 4.45 | 3.26–5.64 | 47 | 3.33 | 3.34 | 2.35–4.33 | 111 | 4.16 | 3.91 | 3.13–4.69 | |
| 2002–2004 | 59 | 4.78 | 4.50 | 3.25–5.76 | 44 | 3.16 | 3.11 | 2.17–4.05 | 103 | 3.92 | 3.83 | 3.05–4.61 | |
| 2005–2007 | 55 | 4.45 | 4.59 | 3.31–5.87 | 41 | 2.95 | 2.81 | 1.94–3.69 | 96 | 3.66 | 3.60 | 2.86–4.33 | |
| 2008–2010 | 48 | 3.91 | 3.82 | 2.63–5.01 | 50 | 3.62 | 3.51 | 2.51–4.50 | 98 | 3.76 | 3.61 | 2.86–4.36 | |
| 2011–2013 | 50 | 4.08 | 3.69 | 2.61–4.77 | 44 | 3.20 | 3.05 | 2.12–3.99 | 94 | 3.61 | 3.43 | 2.70–4.15 | |
| 2014–2017 | 72 | 4.48 | 4.54 | 3.43–5.64 | 74 | 4.13 | 4.10 | 3.07–4.95 | 146 | 4.29 | 4.21 | 3.51–4.92 | |
| Total | 475 | 4.57 | - | - | 407 | 3.49 | - | - | 882 | 4.00 | - | - | |
| 3YMPV | - | - | –3.1 | –6.3/0.2 | - | - | 1.6 | –3.3/6.9 | - | - | –1.0 | –4.2/2.3 | |
aAAR, age-adjusted incidence rate per 100,000 person-years (standard: Europe 2013); NGB, brain malignancies other than GB; CI, confidence intervals; CR, crude incidence rate per 100,000 person-years; No., observed incident cases; 3YMPV, 3-year mean percent variation.